Premium
Alterations in Pregnanediol Excretion in Threatened Premature Labour Following Massive Progestogen Therapy
Author(s) -
Cox R. I.,
Wurm R. S.
Publication year - 1965
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/j.1479-828x.1965.tb00292.x
Subject(s) - pregnanediol , progestogen , excretion , endocrinology , medicine , metrorrhagia , physiology , gynecology , obstetrics , hormone , population , family planning , research methodology , environmental health
Summary: 1. A notable increase in pregnanediol excretion has been found in 9 out of 14 pregnant patients receiving massive Provera therapy, after viability has been reached, to control uterine contractions. 2. The increase in pregnanediol excretion is most apparent 2–3 weeks after commencing Provera treatment. 3. An hypothesis is submitted as a possible explanation of this phenomenon.